Patents by Inventor Mitsubishi Tanabe Pharma Corporation

Mitsubishi Tanabe Pharma Corporation has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARYLALKYLAMINE COMPOUND AND PROCESS FOR PREPARING THE SAME
    Publication number: 20130150374
    Abstract: The present invention relates to an arylalkylamine compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, a process for preparing the same, and use of the above-mentioned compound as an activating compound (CaSR agonist) of a Ca sensing receptor, a pharmaceutical composition containing the above-mentioned compound as an effective ingredient, etc.
    Type: Application
    Filed: December 17, 2012
    Publication date: June 13, 2013
    Applicant: Mitsubishi Tanabe Pharma Corporation
    Inventor: Mitsubishi Tanabe Pharma Corporation
  • TABLET
    Publication number: 20130034607
    Abstract: The present invention provides a novel tablet with improved tablet appearance and improved swallowability. The tablet contains a pharmaceutically acceptable anion exchange resin represented by colestimide as an active ingredient, and has a visibility-resolved tablet edge.
    Type: Application
    Filed: October 12, 2012
    Publication date: February 7, 2013
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventor: Mitsubishi Tanabe Pharma Corporation